Vaccibody ASA is a company headquartered in Norway.
Vaccibody ASA is a Norwegian biotechnology company developing vaccines and immunotherapies using a DNA-based, modular platform that targets antigens to antigen-presenting cells to elicit T-cell and antibody responses. The company focuses on personalised cancer vaccines and vaccines for infectious diseases, and works with partners on clinical development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.